T1	disease_or_phenotypic_feature 54 59	HNPCC
T2	chemical 102 111	inhibitor
T3	chemical 112 125	pembrolizumab
T4	chemical 192 198	oxygen
T5	disease_or_phenotypic_feature 261 285	hepatocellular carcinoma
T6	chemical 309 312;313 322	STS inhibitor
T7	chemical 313 322	inhibitor
T8	chemical 349 352	STS
T9	disease_or_phenotypic_feature 349 352	STS
T10	disease_or_phenotypic_feature 426 433	obesity
T11	chemical 459 469	leuprolide
T12	chemical 470 477	acetate
T13	chemical 503 511	estrogen
T14	chemical 585 594	inhibitor
T15	disease_or_phenotypic_feature 605 613	melanoma
T16	chemical 619 629	vorinostat
T17	chemical 793 802	nutrients
T18	chemical 807 813	oxygen
T19	disease_or_phenotypic_feature 825 846	tumor vascularization
T20	disease_or_phenotypic_feature 848 861	Breast cancer
T21	chemical 872 879	hormone
T22	chemical 895 905	Anesthesia
T23	disease_or_phenotypic_feature 910 917	obesity
T24	chemical 974 988	growth hormone
T25	disease_or_phenotypic_feature 1004 1016	hypogonadism
T26	disease_or_phenotypic_feature 1119 1126	obesity
T27	chemical 1142 1157	dexmedetomidine
T28	chemical 1162 1171	midazolam
T29	disease_or_phenotypic_feature 1185 1193	cataract
T30	chemical 1216 1226	anesthesia
T31	chemical 1228 1239	Sibutramine
T32	chemical 1259 1263	drug
T33	disease_or_phenotypic_feature 1290 1297	obesity
T34	disease_or_phenotypic_feature 1308 1320	hypocalcemia
T35	disease_or_phenotypic_feature 1321 1335	hypomagnesemia
T36	disease_or_phenotypic_feature 1337 1354	hyperphosphatemia
T37	chemical 1368 1377	phosphate
T38	chemical 1413 1419	oxygen
T39	disease_or_phenotypic_feature 1446 1453	obesity
T40	chemical 1518 1524	oxygen
T41	disease_or_phenotypic_feature 1567 1580	heart failure
T42	chemical 1584 1600	Thyroid hormones
T43	disease_or_phenotypic_feature 1604 1611	obesity
T44	disease_or_phenotypic_feature 1614 1624	Lung tumor
T45	chemical 1636 1644	antigens
T46	chemical 1688 1695	aspirin
T47	chemical 1704 1714	inhibitors
T48	disease_or_phenotypic_feature 1730 1743	heart failure
T49	disease_or_phenotypic_feature 1754 1777	coronary artery disease
T50	chemical 1818 1833	povidone-iodine
T51	disease_or_phenotypic_feature 1851 1859	cataract
T52	disease_or_phenotypic_feature 1895 1898	MVD
T53	chemical 1955 1963	estrogen
T54	chemical 1979 1991	progesterone
T55	chemical 2056 2066	inhibitors
T56	disease_or_phenotypic_feature 2076 2084	cataract
R1	treats Arg1:T3 Arg2:T1	
T57	missed_disease_or_phenotypic_feature 127 134	Hypoxia
T58	missed_disease_or_phenotypic_feature 287 290	HCC
R2	treats Arg1:T4 Arg2:T57	
R3	treats Arg1:T4 Arg2:T5	
R4	treats Arg1:T4 Arg2:T58	
T59	corrected_disease_or_phenotypic_feature 580 613	BRAF inhibitor-resistant melanoma
R5	treats Arg1:T16 Arg2:T15	
R6	treats Arg1:T16 Arg2:T59	
R7	treats Arg1:T18 Arg2:T19	
R8	treats Arg1:T31 Arg2:T33	
T60	corrected_chemical 1700 1714	ACE inhibitors
R9	treats Arg1:T46 Arg2:T48	
R10	treats Arg1:T60 Arg2:T48	
R11	treats Arg1:T46 Arg2:T49	
R12	treats Arg1:T60 Arg2:T49	
T61	missed_chemical 293 298	STX64
T62	missed_disease_or_phenotypic_feature 349 352;354 359	STS tumor
R13	treats Arg1:T61 Arg2:T62	
R14	treats Arg1:T6 Arg2:T62	
T63	DONE 2094 2098	DONE
